NOTICE
ANSM - Updated on : 29/09/2020
Product name
IDRYLINE, eye drops solution in single-dose container
Sidebar
Please read this leaflet carefully before taking this medicine, as it contains important information for you.
You must always take this medicine exactly as instructed in this leaflet or by your doctor or pharmacist.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist for advice and information.
- If you experience any side effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. See section 4.
- You should contact your doctor if you do not feel any improvement or if you feel less well after 15 days.
What does this leaflet contain?
1. What is IDRYLINE eye drops in single-dose containers and what is it used for?
2. What do I need to know before taking IDRYLINE, eye drops in single-dose containers?
3. How do I take IDRYLINE eye drops solution in a single-dose container?
4. What are the possible side effects?
5. How should I store IDRYLINE eye drops in single-dose containers?
6. Package contents and other information.
1. WHAT IS IDRYLINE, eye drops in single-dose containers AND WHAT IS IT USED FOR?
Pharmacotherapeutic class: Homeopathic medicines
IDRYLINE is a homeopathic medicine traditionally used in the symptomatic treatment of dry eyes.
2. WHAT DO I HAVE TO KNOW BEFORE TAKING IDRYLINE, eye drops in single-dose containers?
Never take or give IDRYLINE, eye drops in solution in a single-dose container:
- If you are allergic to the active substances or to any of the other ingredients of this medicine, as listed in section 6.
- In children under 12 years of age.
Warnings and precautions
- DO NOT SWALLOW, DO NOT INJECT
- Do not administer into the nose or ear.
- If symptoms do not improve or worsen, consult a doctor.
- In the event of reduced visual acuity, difficulty in holding the eyes open or acute and persistent pain, consult a doctor.
- In case of treatment with another eye drop, space out instillations by 15 minutes.
Children
Not applicable.
Other medicinal products and IDRYLINE, eye drops in solution in single-dose containers
Not applicable.
IDRYLINE, eye drops in single-dose containers with food and drink.
Not applicable.
Pregnancy and breast-feeding
Given the dilution strengths of the strains used in this product, IDRYLINE, eye drops in single-dose containers may be used during pregnancy and breastfeeding.
Driving and use of machinery
Not applicable.
IDRYLINE, eye drops solution in single-dose container contains
Not applicable.
3. HOW TO TAKE IDRYLINE, eye drops in solution in a single-dose container?
For adults and children aged 12 and over.
Dry eyes in children under 12 should be treated by a doctor.
Dosage
1 to 2 drops in each eye, morning and evening, for a minimum of 15 days.
Medical advice should be sought if symptoms persist beyond 15 days.
Method of administration
Ophthalmic route
Wash hands before use.
To ensure that the solution is always sterile , use the product immediately after opening the single-dose container.
1. Open the sachet.
2. Remove one single-dose container. Carefully close the sachet containing the other single-dose containers by folding over the open side.
3. Open the single-dose container by turning the mouthpiece.
4. Place 1 to 2 drops of eye drops into the conjunctival sac, looking upwards, pulling the eyelid slightly downwards and avoiding contact of the tip with the eye or eyelids.
5.blink your eyelids several times to allow the eye drops to spread evenly over the surface of the eye.
This single-dose container does not contain any preservatives, so do not store the opened container for later use.
If you have taken more IDRYLINE eye drops solution in a single-dose container than you should have
Consult your doctor or pharmacist immediately.
If you forget to take IDRYLINE, eye drops in single-dose containers
Do not take or give a double dose to make up for the one you have forgotten to take or give.
If you stop taking IDRYLINE, eye drops in single-dose containers
Not applicable.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Like all medicines, this product may cause undesirable effects, but they do not occur systematically in everyone.
Reporting side effects
If you experience any side effects, please tell your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: Agence nationale de sécurité du médicament et des produits de santé (ANSM) and the network of Regional Pharmacovigilance Centers.
By reporting adverse reactions, you are helping to provide more information on drug safety.
5. HOW TO CONSERVE IDRYLINE, eye drops in solution in single-dose containers?
Keep out of sight and reach of children.
Do not use this medicine after the expiration date indicated on the box. The expiration date refers to the last day of that month. Do not use beyond one month after opening the sachet.
After opening the sachet: keep unused single-dose containers in the sachet.
After opening the single-dose container:
- Discard the single-dose container after use.
- Do not store for future use.
Do not dispose of any medicine down the drain or in the household waste. Ask your pharmacist to dispose of any medicines you no longer use. These measures will help protect the environment.
6. CONTENTS AND OTHER INFORMATION
What IDRYLINE eye drops solution in single-dose container contains
- The active ingredients are :
Alumina 5 CH....................................................................................................................... 0.002 g
Bryonia 5 CH........................................................................................................................ 0.002 g
Nux moschata 5 CH.............................................................................................................. 0.002 g
For a single-dose container of 0.4 ml
- Other components are: Sodium chloride, purified water.
What IDRYLINE is and what it contains.
IDRYLINE is a single-dose eye drop solution. It is packaged in a box containing 30 or 40 single-dose containers.
Not all presentations may be marketed.
Marketing authorization holder
BOIRON
2 avenue de l'Ouest Lyonnais
69510 Messimy
France
Marketing authorization holder
BOIRON
2 avenue de l'Ouest Lyonnais
69510 Messimy
France
Manufacturer
BOIRON
1 rue édouard buffard
zac des frênes
77144 montevrain
france
Product names in member states of the European Economic Area
Not applicable.
The last date on which this leaflet was revised was :
[to be completed subsequently by the holder].
Other
Detailed information on this drug is available on the ANSM (France) website.